Stelara 90MG/ML SYR 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FBTFG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,752
Award facts
- Contract value 100% obligated
- $49,752.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $49,752.39 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90mg/ml syringes. The contract is a firm fixed-price delivery order with an ultimate completion date of December 24, 2025, and was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group operates as the prime contractor with no identified subcontractors on this award.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the DLA, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499.999 billion ceiling value extending through December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to provide the Department of Defense with a comprehensive pharmaceutical supply chain supporting military healthcare facilities worldwide. Through this parent contract vehicle, DLA issues firm fixed-price delivery orders for branded and generic prescription drugs, biologics, and medical consumables, positioning DMS Pharmaceutical Group as a critical supplier for DoD medical operations globally.
Quick answers
Who was awarded contract SPE2DR26FBTFG?
SPE2DR26FBTFG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FBTFG worth?
The government has obligated $49,752 on SPE2DR26FBTFG.
Is contract SPE2DR26FBTFG an order under another contract?
Yes. SPE2DR26FBTFG is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTFG competed?
The extent of competition for SPE2DR26FBTFG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award